The Radiobiology of Targeted Radiotherapy

作者: T.E. Wheldon , J.A. O'Donoghue

DOI: 10.1080/09553009014551401

关键词:

摘要: Targeted radiotherapy consists of biologically selective irradiation malignant cells by means radionuclides attached to tumour-seeking molecules. A variety clinical strategies for targeted may be used, which different normal tissues will critical. large number exist, emitting nuclear particles with a range path lengths from nanometres millimetres. An important feature normal-tissue radiobiology is the dose-rate effect, especially marked late-responding tissues. Radiobiological calculations imply that tolerance dose using low-LET emitters depend strongly on effective half-life radionuclide, affected pharmacokinetics and vary between patients. Some designed improve therapeutic radio (e.g. accelerated clearance radionuclide) have modulating effects dose. Tumour response governed 'four Rs' (repair, repopulation, reoxygenation, redistribution) as well mechanisms peculiar radiotherapy. Analysis based extended linear quadratic model predicts major importance only minority tumours. Most radiation tumour usually delivered over time-scale few days. This might give insufficient time making use hypoxic sensitizers appropriate. special complex relationship curability size radionuclides. For long-range beta-emitters, microscopic tumours operationally resistant because inefficient absorption radionuclide disintegration energy in small volumes. Short-range more efficient sterilization micrometastases but larger require an unattainable degree homogeneity distribution. Optimal it combined external-beam or chemotherapy. Experimental studies necessary investigate those features differ irradiation. Future directions include minimal numbers detected molecular probes. Such applications call short-range alpha-emitters Auger whose become increasingly important.

参考文章(84)
R Dopfer, U Feine, D Niethammer, D Schwabe, J Treuner, F Maul, V Gerein, J Happ, B Kornhuber, T Klingebiel, MIBG-treatment in neuroblastoma; experiences of the Tübingen/Frankfurt group. Progress in Clinical and Biological Research. ,vol. 271, pp. 669- 678 ,(1988)
Frances M. Brodsky, Monoclonal antibodies as magic bullets. Pharmaceutical Research. ,vol. 5, pp. 1- 9 ,(1988) , 10.1023/A:1015860525341
R.O. Dillman, R.M. Bartholomew, P.L. Hagan, A. Chen, S.E. Halpern, L. Krishnan, J. Frincke, G.S. David, D.E. Johnson, D.L. Shawler, Tumor Size: Effect on Monoclonal Antibody Uptake in Tumor Models The Journal of Nuclear Medicine. ,vol. 27, pp. 422- 427 ,(1986)
Eva M. Link, Robert N. Carpenter, Joseph S. Mitchell, Ian Brown, Uptake and Therapeutic Effectiveness of 125I- and 211At-Methylene Blue for Pigmented Melanoma in an Animal Model System Cancer Research. ,vol. 49, pp. 4332- 4337 ,(1989)
Jeffrey A. Mattis, David V. Woo, Derui Li, Zenon Steplewski, Selective chromosomal damage and cytotoxicity of 125I-labeled monoclonal antibody 17-1a in human cancer cells. Cancer Research. ,vol. 49, pp. 2952- 2958 ,(1989)
Scott W. Burchlel, Soldano Ferrone, Noel L. Warner, Kohzoh Imai, John C. Martin, Heterogeneity of HLA-A,B, Ia-like, and Melanom Expression by Human Melanoma Cell Lines Analyzed with Monoclonal Antibodies and Flow Cytometry Cancer Research. ,vol. 42, pp. 4110- 4115 ,(1982)
W. C. Eckelman, M. E. M. Mcmanaway, R. C. Reba, R. E. Gibson, S. M. Larson, B. E. Francis, M. E. Lippman, E. M. Jagoda, Binding Characteristics and Biological Activity of 17α-[125I]Iodovinyl-11β-methoxyestradiol, an Estrogen Receptor-binding Radiopharmaceutical, in Human Breast Cancer Cells (MCF-7) Cancer Research. ,vol. 46, pp. 2386- 2389 ,(1986)
S T Rosen, A M Zimmer, R Goldman-Leikin, L I Gordon, J M Kazikiewicz, E H Kaplan, D Variakojis, R J Marder, M S Dykewicz, A Piergies, Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study. Journal of Clinical Oncology. ,vol. 5, pp. 562- 573 ,(1987) , 10.1200/JCO.1987.5.4.562
Steven M. Larson, Radiolabeled Monoclonal Anti-Tumor Antibodies in Diagnosis and Therapy The Journal of Nuclear Medicine. ,vol. 26, pp. 538- 545 ,(1985)
John W. Babich, Judy S. E. Moyes, Simon T. Meller, Richard Carter, Timothy J. McElwain, Meena Agrawal, Quantitative study of radioiodinated metaiodobenzylguanidine uptake in children with neuroblastoma: correlation with tumor histopathology. The Journal of Nuclear Medicine. ,vol. 30, pp. 474- 480 ,(1989)